—

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 2 Estimated

7MW4911

GI Cancers

Countdown

389days

Phase 2 readout · ~ Jul 31, 2027 estimated

What's at stake Phase 2 trial results for 7MW4911 in GI Cancers are due ~ Jul 31, 2027. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · ClinicalTrials.gov verified 15h ago

“CT.gov NCT07216560: Phase 2 trial, sponsor Mabwell (Shanghai) Bioscience Co., Ltd., drug 7MW4911. Primary completion date 2027-07 (estimated).”

Add to calendar Post on X Reddit

Provenance